SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001615219-24-000040
Filing Date
2024-05-13
Accepted
2024-05-13 16:17:10
Documents
45
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q flks-20240331.htm   iXBRL 10-Q 437842
7 EX-31.1 slrx20240331ex-311.htm EX-31.1 8858
8 EX-31.2 slrx20240331ex-312.htm EX-31.2 8648
9 EX-32.1 slrx20240331ex-321.htm EX-32.1 6185
  Complete submission text file 0001615219-24-000040.txt   2617502

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT flks-20240331.xsd EX-101.SCH 19716
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT flks-20240331_cal.xml EX-101.CAL 23209
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT flks-20240331_def.xml EX-101.DEF 80385
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT flks-20240331_lab.xml EX-101.LAB 279095
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT flks-20240331_pre.xml EX-101.PRE 184726
49 EXTRACTED XBRL INSTANCE DOCUMENT flks-20240331_htm.xml XML 202347
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36812 | Film No.: 24939302
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)